Publication Name	World Journal of Clinical Cases
Manuscript ID	71764
Country	China

Received	2021-10-10 10:25
Peer-Review Started	2021-10-10 10:27
To Make the First Decision
Return for Revision	2021-12-10 02:28
Revised	2021-12-24 15:32
Second Decision	2022-04-29 03:12
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-04-30 07:39
Articles in Press	2022-04-30 07:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-05-31 02:27
Publish the Manuscript Online	2022-06-17 03:19

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Case Report
Article Title	Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature
Manuscript Source	Unsolicited Manuscript
All Author List	Jing-Yi Wu, Kai Kang, Jing Yi and Bin Yang
ORCID	Author(s) ORCID Number Jing-Yi Wu http://orcid.org/0000-0003-1886-5697 Kai Kang http://orcid.org/0000-0002-0429-0346 Jing Yi http://orcid.org/0000-0001-8040-9516 Bin Yang http://orcid.org/0000-0002-2249-2590
Funding Agency and Grant Number
Corresponding Author	Bin Yang, MS, Academic Fellow, Academic Research, Additional Professor, Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Techonology, No.116 Zhuo Daoquan South Road, Wuhan 430000, Hubei Province, China. dlhdr2011@163.com
Key Words	Pembrolizumab; Stevens-Johnson syndrome; Advanced squamous cell carcinoma; Lung; Immune-related adverse events; Case report
Core Tip	Stevens-Johnson syndrome (SJS) is a rare but extremely severe cutaneous adverse drug reaction with high mortality. The case involved a 68-year-old female who was diagnosed with advanced squamous cell carcinoma of the lung. SJS syndrome appeared after one cycle of immunotherapy. After the optimal supportive treatment, skin toxicity disappeared.
Publish Date	2022-06-17 03:19
Citation	Wu JY, Kang K, Yi J, Yang B. Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature. World J Clin Cases 2022; 10(18): 6110-6118
URL	https://www.wjgnet.com/2307-8960/full/v10/i18/6110.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i18.6110

Full Article (PDF)	WJCC-10-6110.pdf
Full Article (Word)	WJCC-10-6110.docx
CARE Checklist–2016	71764-CARE-Checklist–2016-revision.pdf
Manuscript File	71764_Auto_Edited-LJH.docx
Answering Reviewers	71764-Answering reviewers.pdf
Audio Core Tip	71764-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	71764-Conflict-of-interest statement.pdf
Copyright License Agreement	71764-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	71764-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	71764-Language certificate.pdf
Peer-review Report	71764-Peer-review(s).pdf
Scientific Misconduct Check	71764-Bing-Liu JH-2.jpg
Scientific Misconduct Check	71764-CrossCheck.jpg
Scientific Editor Work List	71764-Scientific editor work list.pdf
CrossCheck Report	71764-CrossCheck report.pdf